Targeted nanotechnologies for cancer intervention: a patent review (2010-2016)-Reference-Cited by-同舟云学术

Targeted nanotechnologies for cancer intervention: a patent review (2010-2016)

Published:2017-06-22 Issue:9 Volume:27 Page:1005-1019
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Pradeep Priyamvada¹,Kumar Pradeep¹,Choonara Yahya E.¹,Pillay Viness¹

Affiliation:

1. Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Funder

Cancer Association of South Africa

National Research Foundation (NRF) of South Africa

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1344216

Reference70 articles.

1. Cancer suicide gene therapy: a patent review

2. Recent developments in antitumour platinum coordination compounds

3. Cancer targeted therapeutics: From molecules to drug delivery vehicles

4. Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles;Acta Biomaterialia;2023-10

2. Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications;Materials Today Communications;2023-03

3. Theranostic Applications of Functionalized Polymeric Micelles;Multifunctional And Targeted Theranostic Nanomedicines;2023

4. Atomistic investigations of polymer-doxorubicin-CNT compatibility for targeted cancer treatment: A molecular dynamics study;Journal of Molecular Liquids;2022-02

5. Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression;Frontiers in Pharmacology;2021-06-18